GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

avutometinib   Click here for help

GtoPdb Ligand ID: 11867

Synonyms: Avmapki Fakzynja (avutometinib + defactinib co-pack) | CH-5126766 | CH5126766 | compound 1 [PMID: 24900832] | RG-7304 | RO-5126766 | RO5126766 | VS-6766
Approved drug PDB Ligand
avutometinib is an approved drug
Compound class: Synthetic organic
Comment: Avutometinib (CH5126766; Ro5126766) is a small molecule that acts to inhibit p-MEK and p-ERK downstream of the c-RAF/MEK1 interaction [1,3]. It inhibits the proliferation of BRAFV600E and KRAS mutant cell lines in vitro. Avutometinib is orally active.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species

avutometinib is commercially available from our sponsors

2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 144.69
Molecular weight 471.1
XLogP 2.96
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES CNS(=O)(=O)Nc1nccc(c1F)Cc1c(=O)oc2c(c1C)ccc(c2)Oc1ncccn1
Isomeric SMILES Fc1c(nccc1Cc1c(=O)oc2c(c1C)ccc(c2)Oc1ncccn1)NS(=O)(=O)NC
InChI InChI=1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27)
InChI Key LMMJFBMMJUMSJS-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
Classification Click here for help
Compound class Synthetic organic
Approved drug? Yes. US FDA (2025)
International Nonproprietary Names Click here for help
INN number INN
11815 avutometinib
Synonyms Click here for help
Avmapki Fakzynja (avutometinib + defactinib co-pack) | CH-5126766 | CH5126766 | compound 1 [PMID: 24900832] | RG-7304 | RO-5126766 | RO5126766 | VS-6766
Database Links Click here for help
BindingDB Ligand 50010462
ChEMBL Ligand CHEMBL3264002
DrugBank Ligand DB15254
GtoPdb PubChem SID 461663423
PubChem CID 16719221
RCSB PDB Ligand CHU
Search Google for chemical match using the InChIKey LMMJFBMMJUMSJS-UHFFFAOYSA-N
Search Google for chemicals with the same backbone LMMJFBMMJUMSJS
Search PubMed clinical trials avutometinib
Search PubMed titles avutometinib
Search PubMed titles/abstracts avutometinib
UniChem Compound Search for chemical match using the InChIKey LMMJFBMMJUMSJS-UHFFFAOYSA-N
UniChem Connectivity Search for chemical match using the InChIKey LMMJFBMMJUMSJS-UHFFFAOYSA-N

Product suppliers

View disclaimer

Sponsored products disclaimer

Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.

Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.

✖

MedChemExpress
Avutometinib (links to external site)
Cat. No. HY-18652